Insights into early treatment of mild asthma: do inhaled corticosteroids make a difference?
Approaches to the management of moderate-to-severe persistent asthma in both children and adults are widely accepted but the treatment of mild persistent asthma remains controversial because of the lack of agreement on what constitutes mild asthma and whether regular treatment is required at all. Recent evidence indicates that 'mild asthma' may not be as benign a condition as was widely believed and should be treated to improve asthma control and to prevent the significant burden of exacerbation and progression of disease. This is supported by compelling evidence from histologic and clinical studies that have attributed irreversible pathologic and functional airway changes to consequences of persistent airway inflammation and under-treated asthma. This article focuses on the rationale of early treatment of mild persistent asthma, and discusses the various findings from the largest randomized, early-intervention trial with inhaled corticosteroids as regular treatment in patients with asthma of recent onset--the START (inhaled Steroid Treatment As Regular Therapy in early asthma) study. A brief review of the background of the natural history of asthma, the findings from key longitudinal epidemiologic studies on disease progression in children and adults, and the effect of inhaled corticosteroids on this progression are included, to provide further insight into the impact of early treatment on asthma management guidelines.
Tan
Wan C
WC
University of British Columbia, iCapture Centre for Cardiovascular and Respiratory Diseases, St Paul's Hospital, Vancouver, British Columbia, Canada. wtan@mrl.ubc.ca
D000280:Administration, Inhalation; D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002648:Child; D018450:Disease Progression; D005541:Forced Expiratory Volume / Q000187:drug effects*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index
D005938:Glucocorticoids
Respir Med. 1994 May;88(5):373-81
8036306
Respirology. 2006 Nov;11(6):767-75
17052306
N Engl J Med. 1988 Oct 27;319(17):1112-7
3173442
Am J Respir Crit Care Med. 2002 Jun 1;165(11):1467-8
12045117
Ann Allergy Asthma Immunol. 2005 May;94(5):517-27; quiz 527-9, 574
15945553
Thorax. 2002 Apr;57(4):309-16
11923548
N Engl J Med. 1997 Nov 13;337(20):1412-8
9358138
Trends Pharmacol Sci. 1993 Jul;14(7):275-9
8105598
Am Rev Respir Dis. 1990 Aug;142(2):434-57
2200318
N Engl J Med. 1994 Sep 15;331(11):700-5
8058076
Am Rev Respir Dis. 1993 Nov;148(5):1220-5
8239157
Annu Rev Immunol. 2004;22:789-815
15032597
Thorax. 2002 May;57(5):388-92
11978912
Am Rev Respir Dis. 1993 Apr;147(4):811-7
8466114
J Allergy Clin Immunol. 2005 Apr;115(4):708-13
15805988
Pediatr Allergy Immunol. 2006 May;17 Suppl 17:21-7
16573705
Am Rev Respir Dis. 1993 Mar;147(3):697-704
8442607
Thorax. 1996 Aug;51(8):815-8
8795670
J Allergy Clin Immunol. 1992 Jul;90(1):32-42
1629507
N Engl J Med. 2003 Oct 9;349(15):1414-22
14534334
Pediatr Pulmonol. 1997 Jan;23(1):14-20
9035194
Pediatr Allergy Immunol. 2006 May;17 Suppl 17:14-20
16573704
N Engl J Med. 1991 Aug 8;325(6):388-92
2062329
Thorax. 2006 Feb;61(2):105-10
16308336
Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 1):1308-13
11029336
Ann Allergy Asthma Immunol. 2005 Dec;95(6):566-70
16400897
Control Clin Trials. 2001 Aug;22(4):405-19
11514041
N Engl J Med. 1998 Oct 22;339(17):1194-200
9780339
J Pediatr. 1994 May;124(5 Pt 1):681-8
8176553
Pediatr Allergy Immunol. 1999 May;10(2):89-95
10478609
Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):951-8
9310019
J Allergy Clin Immunol. 2006 Nov;118(5):1040-7
17088127
Am J Respir Crit Care Med. 1995 Sep;152(3):865-71
7663797
Clin Exp Allergy. 1998 May;28(5):568-77
9645593
Am J Respir Crit Care Med. 2005 Aug 15;172(4):410-2; discussion 415-6
16081553
Chest. 2006 Jun;129(6):1478-85
16778264
Pediatr Allergy Immunol. 2006 May;17 Suppl 17:7-13
16573703
N Engl J Med. 2000 Oct 12;343 (15):1054-63
11027739
Eur Respir J. 2002 Jan;19(1):182-91
11843317
N Engl J Med. 2006 Oct 19;355(16):1682-9
17050892
Am J Respir Crit Care Med. 2000 May;161(5):1720-45
10806180
Cochrane Database Syst Rev. 2005 Apr 18;(2):CD005307
15846751
Thorax. 2006 Feb;61(2):100-4
16443705
Proc Am Thorac Soc. 2004;1(3):176-83
16113432
Int J Clin Pract. 2005 Jun;59(6):692-703
15924598
Chest. 1995 Nov;108(5):1228-34
7587421
Clin Chest Med. 2000 Jun;21(2):331-43, ix
10907592
N Engl J Med. 2006 May 11;354(19):1985-97
16687711
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1392-7
11704584
Eur J Respir Dis. 1987 Mar;70(3):171-9
3569449
Can Respir J. 2004 May-Jun;11 Suppl A:9A-18A
15254605
Am Rev Respir Dis. 1980 Feb;121(2):339-42
7362140
Eur Respir J. 2007 Feb;29(2):379-89
17264325
Lancet. 2003 Mar 29;361(9363):1071-6
12672309
N Engl J Med. 2005 Apr 14;352(15):1519-28
15829533
Am Rev Respir Dis. 1992 Jun;145(6):1251-8
1595987
Eur Respir J. 2000 Jan;15(1):151-7
10678638
Am Rev Respir Dis. 1990 Dec;142(6 Pt 1):1407-13
2252260
N Engl J Med. 2001 Feb 1;344(5):350-62
11172168